ArticleAmerican heart journal plus : cardiology research and practice2026
Intra-aortic balloon pump support and early mortality after surgical repair of post-infarction ventricular septal rupture: A 24-year real-world cohort.
Article in American heart journal plus : cardiology research and practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Post-infarction ventricular septal rupture (VSR) remains a rare but highly lethal complication of acute myocardial infarction, with persistently high early mortality. Although surgical repair is the definitive treatment, the optimal perioperative management strategy remains uncertain, particularly regarding the role of intra-aortic balloon pump (IABP) support. Methods: We conducted a retrospective cohort study including consecutive patients with post-infarction VSR who underwent surgical repair at a tertiary cardiovascular centre over a 24-year period. Clinical characteristics, timing of diagnosis and surgery, use and timing of IABP support, and 30-day all-cause mortality were analysed. Multivariable logistic regression was performed to identify independent predictors of early mortality. Patients managed conservatively or treated exclusively with percutaneous closure were not included. Results: A total of 59 patients were included (mean age 65.3 ± 10.2 years; 57.6% male). Overall 30-day mortality was 54.4%. IABP support was used in 64.4% of patients, including 33.9% pre-operatively and 30.5% post-operatively. Non-survivors experienced longer delays from symptom onset to surgery and from hospital admission to surgery. In multivariable analysis, post-operative IABP use was independently associated with lower 30-day mortality (OR 0.014, 95% CI 0.001-0.120; Conclusions: In this real-world cohort characterised by delayed diagnosis and referral, perioperative IABP support was strongly associated with improved early survival after surgical repair of post-infarction VSR, supporting its pragmatic role as haemodynamic support in selected patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.